Q32 Bio (QTTB) Earnings Date & Reports

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

QTTB is expected to report earnings to fall 47.37% to -30 cents per share on March 28

Q4'23

Est.

$-0.30

Q3'23

Missed

by $0.14

Q2'23

Missed

by $0.11

Q1'23

Beat

by $0.02

Q4'22

Missed

by $10.31

The last earnings report on November 14 showed earnings per share of -56 cents, missing the estimate of -43 cents. With 56.52K shares outstanding, the current market capitalization sits at 19.88M.

View a ticker or compare two or three

Compare

QTTB